EBOLA VIRUS DISEASE AND ITS COMPLICATIONS

Raj K Keservani; Anil K Sharma; Urmila Jarouliya; Amit Kumar Singh

doi:10.22270/ujpr.v1i1.RW1

Raj K Keservani School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, 462033, India
Anil K Sharma Department of Pharmaceutics, Delhi Institute of Pharmaceutical Sciences and Research, New Delhi, 110017, India.
Urmila Jarouliya School of Studies in Biotechnology, Jiwaji University, Gwalior (M.P.), 474011, India.
Amit Kumar Singh Faculty of Pharmaceutics, United Institute of Pharmacy, UCER, Allahabad, 211008, India.

10.22270/ujpr.v1i1.RW1

Keywords:

Ebola virus, ebola virus disease (evd), hemorrhagic fever, filoviruses

Abstract

In African countries Ebola virus has been responsible for several deaths. In addition to being a global health concern, the virus is also considered a potential biological threat. Ebola viruses are incompletely understood pathogens that cause severe, often fatal, illnesses in humans and non-human primates. Ebola virus disease affects most of the human being and finally mortality rate increases in that county. Most of the countries are on alert for the ebola virus because peoples have worked within the boundaries of the affected area of Africa. Such people are not permitted to enter in the resident country without proper test at airport or other places. In this review we have discussed ebola virus disease and it affects the peoples worldwide.

Peer Review History:

Article received on- 5 August; Revised 10 September; Accepted 12 October; Available online 15 November 2016

Academic Editor: Dr. DANIYAN Oluwatoyin Michael, Obafemi Awolowo University, ILE-IFE, Nigeria, toyinpharm@gmail.com

Received file: Reviewer's Comments:

Average Peer review marks at initial stage: 5.0/10

Average Peer review marks at publication stage: 7.5/10

Reviewer(s) detail:

Dr. Viney Chawla, University Institute of Pharmaceutical Sciences, Baba Farid University of Health Sciences, Sadiq Road, Faridkot-Punjab 151203, drvineychawla@gmail.com

Dr. Tamer Elhabibi, Suez Canal University, Egypt, tamer_hassan@pharm.suez.edu.eg